Financing Cash Flow
AbbVie Financing Cash Flow increased by 9.2% to -$4.17B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 39.3%, from -$6.86B to -$4.17B. Over 4 years (FY 2021 to FY 2025), Financing Cash Flow shows an upward trend with a -9.6% CAGR.
Analysis
How to read this metric
A large negative value typically indicates a company is returning capital to shareholders or paying down debt, while a positive value suggests the company is raising external capital to fund operations or acquisitions.
Detailed definition
This metric represents the net flow of cash between a company and its capital providers, including shareholders and lend...
Peer comparison
Large-cap peers like Microsoft or Alphabet similarly show large negative financing outflows due to aggressive share repurchase programs and dividend distributions.
cf_net_cash_from_financingHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$5.88B | -$3.64B | -$6.34B | -$6.97B | -$2.68B | -$5.52B | -$9.63B | -$6.19B | -$3.92B | -$2.66B | -$4.45B | $10.82B | -$6.10B | -$3.07B | -$6.86B | -$1.26B | -$2.71B | -$4.59B | -$4.17B |
| QoQ Change | — | +38.1% | -74.0% | -10.0% | +61.6% | -106.0% | -74.6% | +35.7% | +36.7% | +32.1% | -67.2% | +343.2% | -156.4% | +49.6% | -123.3% | +81.7% | -115.4% | -69.4% | +9.2% |
| YoY Change | — | — | — | — | +54.5% | -51.5% | -52.0% | +11.2% | -46.3% | +51.8% | +53.8% | +274.7% | -55.5% | -15.4% | -54.2% | -111.6% | +55.6% | -49.4% | +39.3% |
Financing Cash Flow at Other Companies
Frequently Asked Questions
- What is AbbVie's financing cash flow?
- AbbVie (ABBV) reported financing cash flow of -$4.17B in Q4 2025.
- How has AbbVie's financing cash flow changed year-over-year?
- AbbVie's financing cash flow increased by 39.3% year-over-year, from -$6.86B to -$4.17B.
- What is the long-term trend for AbbVie's financing cash flow?
- Over 4 years (2021 to 2025), AbbVie's financing cash flow has grown at a -9.6% compound annual growth rate (CAGR), from -$19.04B to -$12.72B.
- What does financing cash flow mean?
- The total amount of money a company spends or receives from borrowing debt and managing its own shares and dividends.